Why the Mounjaro pen has an extra dose — and what to do about it

Each Mounjaro KwikPen is filled with slightly more liquid than four standard weekly doses to ensure accurate delivery every time the device is used.
The extra volume exists to prime the needle and compensate for the mechanics of the pen, it is engineered surplus, not a clinically prescribed extra dose.
Using the residual liquid as an additional dose is not recommended; the pen is not calibrated to deliver a consistent amount once the four standard doses have been given.
Any uncertainty about how many doses your pen contains, or what to do with remaining medicine, should be resolved with your prescriber or a pharmacist before you act.

The Mounjaro KwikPen is labelled as containing four weekly doses, yet many people find the pen still has medicine left after the fourth injection. That fifth portion of liquid is real, and it is there by design. Each pen is filled with slightly more than the four nominal doses to account for the small amount of medicine needed to prime the needle and prime the device itself — it is not a spare dose intended for use. Whether that leftover fluid can or should be used is a question our prescribers hear regularly, and the answer matters more than it might appear at first glance. Mounjaro is a prescription-only medicine, and any decision about how doses are drawn or used must be guided by your prescriber and the Patient Information Leaflet, not by the fact that liquid remains.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The detail behind the extra liquid, and why it shapes what you should do next

Why does every Mounjaro pen contain more liquid than four doses should need?

Eli Lilly fills each KwikPen with a volume that exceeds the sum of four individual doses. This is standard pharmaceutical practice for pre-filled injection devices. A small amount of medicine is consumed each time the pen is primed before an injection, the brief forward push that clears air from the needle. The device's internal mechanics also retain a thin layer of liquid that never reaches the needle tip. These two factors together mean that if you measure the fill precisely, the pen holds enough for four full doses plus a remainder. The Mounjaro SmPC on the eMC treats this overfill as functional, not therapeutic: the pen is designed and calibrated to deliver four injections of the labelled strength. Nothing about the remaining volume changes your prescribed schedule.

It is worth knowing that this is true across all six Mounjaro strengths, from the 2.5 mg starter through to 15 mg. The absolute volume in the pen changes with the strength, but the principle is the same at every step of the titration ladder, and our page on the Mounjaro KwikPen extra dose explains in detail how that remaining volume behaves across each strength.

Can you actually use what's left in the pen after the fourth dose?

This is where the question gets more involved, and where the reassurance you might hope for is genuinely hard to give. The pen's dose-metering mechanism is designed around four actuations. Once those four doses have been delivered, the remaining fluid has not been measured by the device, there is no calibrated mechanism left to ensure the residual volume equals a full therapeutic dose. You might get less than you expect, or the pen might not actuate cleanly at all.

Our clinical team would flag two further points. First, using unlabelled residual medicine introduces real uncertainty about the dose you have received, which matters when tirzepatide is titrated carefully by a prescriber over months. Second, the pen and needle should be disposed of safely after the fourth dose, and if you want a fuller picture of what that leftover liquid actually represents, our page on the Mounjaro extra dose explains the pharmacology and the safe-handling considerations together. The NHS guidance on tirzepatide is clear that the device should be used as instructed, and that your prescriber is the right person to contact if anything about your pen seems unusual.

Does discovering extra liquid mean your previous doses were under-delivered?

This is the worry sitting underneath most of the questions we see on this topic. If there is liquid left, does that mean earlier injections were incomplete? In the vast majority of cases, no. The residual volume is the engineered overfill described above, not evidence of a dosing failure. Provided the pen actuated correctly and you followed the injection technique (needle inserted fully, button held down, a slow count before withdrawal) the labelled dose was delivered.

Injection technique does, however, genuinely affect delivery. If the needle was withdrawn too quickly, or the button was not fully depressed, some medicine may have been lost at the skin surface. If you have a consistent concern about this, it is worth raising with your prescriber at your next review rather than trying to compensate by using the residual liquid. A brief note on what it means when the pen appears to have five doses covers the technique angle in more detail. The short version: a correctly used pen's overfill is not a sign that anything went wrong.

What should you do if you have questions about your pen before your next dose?

If you have just found liquid in what should be an empty pen and you are unsure what to do, the right sequence is straightforward. Do not inject the remainder. Dispose of the pen and needle safely, a sharps container is the right destination for used pens; standard household bins are not. Then contact your prescriber. If you are on treatment through a service that offers ongoing support, that team should be your first call. At nume, aftercare is available seven days a week precisely because these practical questions come up between scheduled reviews.

For people weighing up the broader picture of how Mounjaro is priced and what a private prescription includes, our Mounjaro price comparison page sets out what legitimate private treatment costs and what that price should cover. A prescription medicine dispensed through a GPhC-registered pharmacy (verifiable at that link) should come with clinical oversight that makes questions like this easy to ask. If it does not, that is worth knowing before your next order.

If you are not yet on treatment and are trying to understand how the pen works before starting, our page covering whether you can use the extra dose in a Mounjaro pen is a useful place to read before your first injection, alongside our Mounjaro overview, which covers the KwikPen device, the titration schedule, and what a consultation involves. Speak to our prescribers when you are ready, the consultation is free and reviewed the same day by a real clinician.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions